Healthcare provider profile · identity verified

Susan Lynn Crowe, M.D.

Family Practice · LAKELAND, FL · NPI 1982729521

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	371	120
Rosuvastatin Calcium	Rosuvastatin Calcium	340	105
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	262	47
Albuterol Sulfate Hfa	Albuterol Sulfate	260	111
Fluticasone Propionate	Fluticasone Propionate	258	124
Azithromycin	Azithromycin	254	135
Losartan Potassium	Losartan Potassium	253	83
Pantoprazole Sodium	Pantoprazole Sodium	242	87
Levothyroxine Sodium	Levothyroxine Sodium	231	73
Ozempic	Semaglutide	215	40
Gabapentin	Gabapentin	213	73
Amlodipine Besylate	Amlodipine Besylate	206	60
Lisinopril	Lisinopril	200	64
Metoprolol Succinate	Metoprolol Succinate	193	63
Metformin Hcl	Metformin Hcl	171	55
Omeprazole	Omeprazole	161	61
Allopurinol	Allopurinol	158	45
Furosemide	Furosemide	158	69
Carvedilol	Carvedilol	153	40
Prednisone	Prednisone	145	79
Duloxetine Hcl	Duloxetine Hcl	139	39
Glipizide	Glipizide	138	40
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	134	20
Montelukast Sodium	Montelukast Sodium	133	44
Metoprolol Tartrate	Metoprolol Tartrate	129	46
Eliquis	Apixaban	117	21
Trazodone Hcl	Trazodone Hcl	115	41
Tramadol Hcl	Tramadol Hcl	114	30
Diclofenac Sodium	Diclofenac Sodium	113	77
Warfarin Sodium	Warfarin Sodium	112	30
Triamcinolone Acetonide	Triamcinolone Acetonide	111	61
Famotidine	Famotidine	109	47
Hydrochlorothiazide	Hydrochlorothiazide	109	33
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	108	48
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	102	20
Alendronate Sodium	Alendronate Sodium	100	40
Tamsulosin Hcl	Tamsulosin Hcl	93	32
Tizanidine Hcl	Tizanidine Hcl	89	36
Jardiance	Empagliflozin	83	19
Ondansetron Odt	Ondansetron	83	48
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	82	50
Clopidogrel	Clopidogrel Bisulfate	82	27
Sertraline Hcl	Sertraline Hcl	80	23
Ibuprofen	Ibuprofen	76	37
Alprazolam	Alprazolam	72	13
Potassium Chloride	Potassium Chloride	71	27
Quetiapine Fumarate	Quetiapine Fumarate	71	18
Simvastatin	Simvastatin	70	19
Fluconazole	Fluconazole	67	35
Nystatin	Nystatin	66	34
Sumatriptan Succinate	Sumatriptan Succinate	64	12
Citalopram Hbr	Citalopram Hydrobromide	62	17
Meloxicam	Meloxicam	62	23
Metformin Hcl Er	Metformin Hcl	60	18
Methylprednisolone	Methylprednisolone	60	47
Escitalopram Oxalate	Escitalopram Oxalate	59	20
Spironolactone	Spironolactone	58	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	55	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	43
Mupirocin	Mupirocin	48	35
Glipizide Er	Glipizide	47	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	12
Pregabalin	Pregabalin	47	17
Hydroxyzine Hcl	Hydroxyzine Hcl	46	18
Clonidine Hcl	Clonidine Hcl	44	13
Finasteride	Finasteride	44	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	11
Celecoxib	Celecoxib	43	15
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Nifedipine Er	Nifedipine	42	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	11
Amoxicillin	Amoxicillin	41	23
Meclizine Hcl	Meclizine Hcl	40	21
Acetaminophen-Codeine	Acetaminophen With Codeine	38	14
Ezetimibe	Ezetimibe	37	12
Ibandronate Sodium	Ibandronate Sodium	37	11
Clonazepam	Clonazepam	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Glimepiride	Glimepiride	35	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Naproxen	Naproxen	34	18
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Sildenafil Citrate	Sildenafil Citrate	33	12
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	32	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	12
Mirtazapine	Mirtazapine	29	suppressed
Propranolol Hcl	Propranolol Hcl	28	11
Diazepam	Diazepam	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	11
Myrbetriq	Mirabegron	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	11
Solifenacin Succinate	Solifenacin Succinate	26	11
Doxycycline Monohydrate	Doxycycline Monohydrate	25	18
Lorazepam	Lorazepam	24	suppressed
Risperidone	Risperidone	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Cilostazol	Cilostazol	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Baclofen	Baclofen	22	15
Memantine Hcl	Memantine Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Temazepam	Temazepam	22	suppressed
Cephalexin	Cephalexin	21	16
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Novolin R	Insulin Regular, Human	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Atenolol	Atenolol	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Varenicline Tartrate	Varenicline Tartrate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Levofloxacin	Levofloxacin	17	11
Lidocaine Hcl Viscous	Lidocaine Hcl	17	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	17	suppressed
Topiramate	Topiramate	16	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Calcitriol	Calcitriol	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Digoxin	Digoxin	14	suppressed
Estradiol	Estradiol	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Metolazone	Metolazone	14	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Carvedilol Er	Carvedilol Phosphate	13	suppressed
Cefdinir	Cefdinir	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error